Controlling Hyperactive Immunity With Long-lived Lymphocytes
NCT07473154
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Diffuse Cutaneous Systemic Sclerosis
Rheumatoid Arthritis (RA)
Systemic Sclerosis (SSc)
Autoimmune Rheumatologic Disease
Interventions
DRUG:
QEL-005
Sponsor
Quell Therapeutics Limited